Your browser doesn't support javascript.
loading
Response to rapamycin analogs but not PD-1 inhibitors in PTEN-mutated metastatic non-small-cell lung cancer with high tumor mutational burden.
Parikh, Ankur R; Ali, Siraj M; Schrock, Alexa B; Albacker, Lee A; Miller, Vincent A; Stephens, Phil J; Crilley, Pamela; Markman, Maurie.
Affiliation
  • Parikh AR; Eastern Regional Medical Center, Cancer Treatment Centers of America, Philadelphia, PA, USA.
  • Ali SM; Foundation Medicine, Inc, Cambridge, MA, USA.
  • Schrock AB; Foundation Medicine, Inc, Cambridge, MA, USA.
  • Albacker LA; Foundation Medicine, Inc, Cambridge, MA, USA.
  • Miller VA; Foundation Medicine, Inc, Cambridge, MA, USA.
  • Stephens PJ; Foundation Medicine, Inc, Cambridge, MA, USA.
  • Crilley P; Eastern Regional Medical Center, Cancer Treatment Centers of America, Philadelphia, PA, USA.
  • Markman M; Eastern Regional Medical Center, Cancer Treatment Centers of America, Philadelphia, PA, USA.
Lung Cancer (Auckl) ; 9: 45-47, 2018.
Article in En | MEDLINE | ID: mdl-29844707
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Lung Cancer (Auckl) Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Lung Cancer (Auckl) Year: 2018 Document type: Article Affiliation country: Country of publication: